Provided By GlobeNewswire
Last update: Sep 10, 2024
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response
LIFEHAB is a Randomized Controlled Trial in Norway Comparing Lumbar Interbody Fusion Surgery With Multidisciplinary Rehabilitation
Read more at globenewswire.comNASDAQ:ACONW (12/1/2025, 8:00:00 PM)
0.0487
+0.01 (+21.75%)
NASDAQ:ACON (12/1/2025, 8:00:00 PM)
6.5
+0.24 (+3.83%)
Find more stocks in the Stock Screener


